Company Description
Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States.
The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.
The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease.
In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions.
The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
| Country | United States |
| Founded | 1997 |
| IPO Date | Sep 21, 2004 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 31 |
| CEO | Robert Banks |
Contact Details
Address: 380 Lackawanna Place South Orange, New Jersey 07079 United States | |
| Phone | 201.343.5202 |
| Website | nephros.com |
Stock Details
| Ticker Symbol | NEPH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001196298 |
| CUSIP Number | 640671400 |
| ISIN Number | US6406714005 |
| Employer ID | 13-3971809 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert Banks | President, Chief Executive Officer and Director |
| Judy F. Krandel C.F.A. | Chief Financial Officer |
| Alfred Vargas | Director of Operations |
| Brianne McGuire | Director of Brand, Marketing and Business Development |
| Vashone R. Thomas | Vice President of Quality, Regulatory, and Human Resources |
| Daron G. Evans M.B.A., M.S. | Chief Executive Officer of Specialty Renal Products, Inc |
| Greg Lucas | President of Aether Water Systems |
| Judy Mazzini | Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 12, 2024 | ARS | Filing |
| Apr 12, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 12, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 15, 2024 | 10-K | Annual Report |
| Mar 7, 2024 | 8-K | Current Report |
| Nov 8, 2023 | 10-Q | Quarterly Report |
| Nov 6, 2023 | 8-K | Current Report |
| Aug 9, 2023 | 8-K | Current Report |
| Aug 9, 2023 | 10-Q | Quarterly Report |
| Jun 1, 2023 | 8-K | Current Report |